Clinical Trial Update: Study to Investigate the Effect of AB-101 in Breast Cancer Survivors [EARLY_Phase 1]

View source ↗

Summary

Early-phase study investigating AB-101 in breast cancer survivors; study completed with results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Neuropathy
• Nipple Disorder
• Sexual Arousal Disorder
• Sexual Dysfunction

Drugs mentioned

• AB-101

Snippet

Sponsor: Applied Biology, Inc. | Conditions: Sexual Dysfunction, Sexual Arousal Disorder | EARLY_Phase 1 | Status: COMPLETED | Results posted: 2020-03-12